Evaluation of Annexins Family as Potential Biomarker for Predicting Progression and Prognosis in Clear Renal Cell Carcinoma.
Jiyu ZhaoLuchen ChangJianping TuBei SunXi WeiPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
Our study implies that ANXA4/8/13 are potential targets of precision therapy for patients with KIRC and that ANXA2/5/8/10 are new biomarkers for the prognosis of KIRC.
Keyphrases